ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Denosumab Boosts BMD after Teriparatide Treatment for Osteoporosis

Marilynn Larkin  |  

NEW YORK (Reuters Health)—After discontinuation of teriparatide, increases in bone mineral density (BMD) are greater with denosumab than with zoledronic acid, but whether that translates into a decreased fragility fracture risk remains unknown, researchers say. Teriparatide was the first anabolic treatment approved for osteoporosis in the U.S. It has been shown to increase BMD, and…

FDA’s Gottlieb Eyes PBM Consolidation Impact on Generic Entry: CNBC

Reuters Staff  |  

NEW YORK (Reuters)—The head of the U.S. Food & Drug Administration Scott Gottlieb said on Wednesday that he was concerned about the impact of deals like the CVS Health purchase of Aetna Inc. on the ability of pharmaceutical companies to block the entry of cheaper copycat drugs. As the pharmacy benefit managers and the drug…

Chikungunya Arthritis

Arthritis & Rheumatology  |  

In this review, the authors address the key pathophysiologic mechanisms that drive acute and chronic chikungunya arthritis, arguably the most incapacitating sequela among long-lasting chikungunya virus disease manifestations, based on recent animal experimental disease models and epidemiologic studies. They explore the latest findings in therapeutic development aimed at limiting viral spread and at immune and…

Baricitinib Appears Effective in Biologic-Refractory RA

Reuters Staff  |  

NEW YORK (Reuters Health)—The selective Janus kinase 1 and 2 inhibitor baricitinib appears also to help patients whose rheumatoid arthritis (RA) has not responded adequately to biologic disease-modifying antirheumatic drugs, according to results from the RA-BEACON randomized trial. The previously published overall results from RA-BEACON showed that baricitinib-treated patients had significantly better functional and clinical…

Sialendoscopy Enhances Salivary Flow in Sjogren’s Syndrome

Will Boggs MD  |  

NEW YORK (Reuters Health)—Sialendoscopy with irrigation of the major salivary glands can enhance salivary flow and reduce xerostomia in patients with Sjogren’s syndrome, according to a randomized trial. “In our study it is suggested that patients with recent onset of Sjogren’s syndrome and with residual salivary gland capacity could benefit from sialendoscopy,” said Dr. Derk…

ACR Members Begin Work on CMS Committees

  |  

TEP In February, Lisa Gale Suter, MD, joined the Technical Expert Panel (TEP) for the Centers for Medicare & Medicaid Services (CMS) Quality Measure Development Plan, supporting the transition to the Merit-Based Incentive Payment System (MIPS) and Alternative Payment Models (APMs). She was nominated to serve in this role by the ACR. The panel comprises…

Providers Using RISE Have Advantage with 2017 MIPS Reporting

  |  

Hundreds of rheumatology providers across the country are finalizing submissions for the first year of reporting under the Merit-Based Incentive Payment System (MIPS). According to a presentation at the 2017 ACR/ARHP Annual Meeting in San Diego, providers that participate in and submit through the Rheumatology Informatics System for Effectiveness (RISE) Registry are poised to perform…

Invest in RheumPAC Now to Support the Future of Rheumatology

Ryan Jessee, MD  |  

If there’s one thing America needs right now, it’s more money in politics. I’m being facetious, but I do want to ask all of you to invest in RheumPAC today. Given the relatively small size of our subspecialty, it is easy for lawmakers to overlook the consequences that laws may have on our field of…